Skip to main content

Table 3 Relationship between TRIB3 expression and clinicopathological parameters of ovarian epithelial malignant tumors

From: Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway

Groups Cases Low High Positive rate (%) P-value High expression rate (%) P-value
(−) (+) (++) (+++)
FIGO stage
 I–II 36 11 7 9 9 69.4 P = 0.279 50.0 P = 0.414
 III–IV 58 12 12 14 20 79.3 58.6
Differentiation
 Well-moderate 46 9 9 14 14 80.4 P = 0.279 60.9 P = 0.289
 Poor 48 14 10 9 15 70.8 50
Lymphatic metastasis
 No 60 16 9 18 17 73.3 P = 0.540 58.3 P = 0.229
 Yes 27 6 9 3 9 79.3 41.4
 Unknowna 7 1 1 2 3 85.7 71.4
Pathological type
 Serous 46 10 12 10 14 78.3 P = 0.371 52.2 P = 0.786
 Mucinous 10 4 1 2 3 60 50
 Endometrioid 14 3 2 4 5 78.6 64.3
 Clear cell carcinoma 6 3 1 1 1 50 33.3
 Poorly differentiated adenocarcinoma 18 3 3 6 6 83.3 66.
  1. a 7 patients without lymphadenectomy